Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UC Davis
- Dates
- study startedcompletion around
Description
Summary
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Skingenix, Inc.
- ID
- NCT01297400
- Phase
- Phase 2 Burns Research Study
- Study Type
- Interventional
- Participants
- Expecting 60 study participants
- Last Updated